Mistras Group (NYSE:MG) Rating Increased to Hold at Zacks Investment Research

Share on StockTwits

Zacks Investment Research upgraded shares of Mistras Group (NYSE:MG) from a sell rating to a hold rating in a research report released on Thursday, Zacks.com reports.

According to Zacks, “Mistras Group, Inc. is a global provider of technology-enabled, non-destructive testing (NDT) solutions used to evaluate the structural integrity of critical energy, industrial and public infrastructure. The Company delivers a portfolio of solutions, ranging from routine NDT inspections to plant-wide asset integrity assessment and management solutions. The Company serves a global customer base, including companies in the oil and gas, fossil and nuclear power generation and transmission, public infrastructure, chemicals, aerospace and defense, transportation, primary metals and metalworking, pharmaceuticals and food processing industries. “

Several other equities analysts also recently issued reports on the company. Maxim Group cut their target price on Mistras Group to and set a buy rating on the stock in a research report on Tuesday, February 11th. ValuEngine raised shares of Mistras Group from a hold rating to a buy rating in a report on Tuesday, February 4th. Finally, TheStreet lowered shares of Mistras Group from a c- rating to a d+ rating in a report on Friday, February 14th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Mistras Group presently has an average rating of Hold and an average target price of $25.38.

Shares of NYSE:MG opened at $10.01 on Thursday. The company has a market capitalization of $289.44 million, a price-to-earnings ratio of 71.50, a price-to-earnings-growth ratio of 1.33 and a beta of 1.33. Mistras Group has a 52 week low of $9.19 and a 52 week high of $16.95. The company has a quick ratio of 1.61, a current ratio of 1.73 and a debt-to-equity ratio of 0.98. The firm has a 50 day moving average of $11.94 and a 200 day moving average of $13.99.

Large investors have recently added to or reduced their stakes in the stock. Great West Life Assurance Co. Can bought a new position in shares of Mistras Group during the fourth quarter worth about $30,000. California Public Employees Retirement System boosted its stake in Mistras Group by 29.1% during the 3rd quarter. California Public Employees Retirement System now owns 15,323 shares of the technology company’s stock valued at $251,000 after acquiring an additional 3,457 shares during the last quarter. Barclays PLC boosted its holdings in shares of Mistras Group by 102.1% in the fourth quarter. Barclays PLC now owns 18,193 shares of the technology company’s stock worth $260,000 after buying an additional 9,193 shares during the period. UBS Group AG raised its position in Mistras Group by 74.9% during the fourth quarter. UBS Group AG now owns 23,939 shares of the technology company’s stock valued at $341,000 after acquiring an additional 10,255 shares in the last quarter. Finally, Envestnet Asset Management Inc. raised its position in Mistras Group by 5.1% during the fourth quarter. Envestnet Asset Management Inc. now owns 28,384 shares of the technology company’s stock valued at $405,000 after acquiring an additional 1,375 shares in the last quarter. 56.88% of the stock is currently owned by institutional investors and hedge funds.

About Mistras Group

Mistras Group, Inc provides technology-enabled asset protection solutions worldwide. The company operates through three segments: Services, International, and Products and Systems. It offers traditional non-destructive testing, and inspection and testing program services; and engineering consulting services.

Recommended Story: Death Cross

Get a free copy of the Zacks research report on Mistras Group (MG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Mistras Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mistras Group and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.